⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
BIAFW News
bioAffinity Technologies, Inc. Warrant
bioAffinity Technologies Reports Third Quarter 2026 Results and Continued Momentum in CyPath® Lung Commercialization
businesswire.com
BIAFW
BIAF
Form 8-K
sec.gov
BIAFW
BIAF
Form 8-K
sec.gov
BIAF
BIAFW
Form 8-K
sec.gov
BIAFW
BIAF
Form 8-K
sec.gov
BIAF
BIAFW
Form 8-K
sec.gov
BIAF
BIAFW
WallachBeth Capital Announces Closing of bioAffinity Technologies $4 Million Registered Direct Financing of Common Stock and Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules
prnewswire.com
BIAFW
BIAF
WallachBeth Capital Announces bioAffinity Technologies Approximately $4 Million Registered Direct Financing of Common Stock and Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules
prnewswire.com
BIAFW
BIAF
Form 8-K
sec.gov
BIAF
BIAFW
Form 8-K
sec.gov
BIAF
BIAFW